<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Genpharmasec Ltd has filed an initial disclosure under SEBI guidelines for entities identified as Large Corporates. This is a regulatory compliance requirement where companies meeting certain thresholds must disclose details related to their borrowings and financial commitments. The filing follows SEBI circular requiring large corporates to make half-yearly disclosures regarding their outstanding borrowings. Note: The full document details were not accessible due to a BSE page error, but the filing type indicates standard regulatory compliance.
This is a routine regulatory filing with no direct impact on stock price. It confirms the company's status under SEBI's Large Corporate framework, which carries specific disclosure and borrowing norms.